Skip to main content
NIH
Forecasted

RFA-AI-27-016

Tuberculosis Research Advancement Centers (TRACs)

Summary

AI-generated

Tuberculosis Research Advancement Centers (TRACs)

NIAID is funding Tuberculosis Research Advancement Centers (TRACs) to strengthen the TB research ecosystem through mentorship, training, and collaborative science. TRACs serve as regional or thematic hubs that support early-career investigators and researchers transitioning into TB work, spanning basic mycobacterial immunology, host-pathogen interactions, TB diagnostics, drug development, and clinical TB research. Beyond individual investigator development, TRACs provide pilot funding for high-impact collaborative studies across centers and resources for translational research bridging bench discoveries to clinical applications. The program aims to build sustainable research networks and accelerate progress on TB pathogenesis, prevention, and treatment.

  • Who can apply: Institutions with established TB research capacity and leadership; early-career investigators and those new to TB research are primary trainees (institutional eligibility not fully specified).
  • Funding & project length: Not stated.
  • Award mechanism: Center grant with pilot award and training components.
  • Key dates: Not stated.
  • Best fit for: Mycobacterial immunologists, clinical TB researchers, and translational scientists seeking mentorship networks, pilot funding, and collaborative partnerships within a structured research center.

Insights (5)

Early Career Investigator Training Infrastructure Provides Structured Mentorship and Pilot Funding

career stage

TRACs explicitly prioritize mentoring and training early career investigators and those new to TB research, offering both scientific leadership and administrative support. This positions ESI/NSI applicants as ideal candidates and provides a structured pathway to establish TB research programs through pilot awards and collaborative opportunities within the network.

Mycobacterial Immunology and Host-Pathogen Research Align with NIAID TB Research Priorities

strategic fit

The enrichment keywords (mycobacterial immunology, host-pathogen interactions, TB pathogenesis) directly map to NIAID's TB research mission. Applicants with preliminary data or expertise in these mechanistic areas will be competitive, particularly if they can demonstrate how their work advances understanding of TB biology or clinical outcomes.

Multi-Center TRAC Network Requires or Strongly Incentivizes Collaborative Research Design

collaboration

The program explicitly funds "collaborative studies with other TRACs" and emphasizes "collaborative research networks." Applicants should consider whether their research benefits from or requires partnership with other TB research centers, as the program structure rewards consortium approaches and cross-center pilot projects.

Pilot Award and Training Focus Suggests Moderate Competition with Emphasis on Feasibility

competition

TRACs fund both short-term pilot awards and training initiatives, not large-scale independent research programs. This mechanism typically attracts a focused applicant pool and favors preliminary data, proof-of-concept studies, and training proposals over fully developed research programs, reducing competition from established investigators with large existing portfolios.

Administrative and Mentorship Infrastructure Requirements May Favor Established Research Centers

eligibility

TRACs must provide "scientific leadership and administrative support" to mentor early career investigators, implying that applicant institutions need existing TB research infrastructure, faculty capacity, and administrative resources. Smaller institutions or those without established TB programs may face practical barriers to meeting these expectations, even if their scientific vision is strong.

Key Facts

Deadline

Posted

Tue, December 16, 2025

Keywords

tuberculosis research
early career investigator training
mycobacterial immunology
clinical TB research
TB diagnostics
host-pathogen interactions
collaborative research networks
TB drug development
translational research
TB pathogenesis
basic TB research
antimicrobial resistance
pilot studies

Research Areas

NIH Institute
Allergy & Infectious DiseasesNIAID
OpenAlex
Life SciencesD1Health SciencesD4
Fields
Biochemistry, Genetics & Molecular BiologyF13Immunology & MicrobiologyF24MedicineF27Pharmacology, Toxicology & PharmaceuticsF30
Subfields
GeneticsS1311Molecular BiologyS1312ImmunologyS2403MicrobiologyS2404VirologyS2406EpidemiologyS2713Infectious DiseasesS2725Public Health & Occupational HealthS2739Drug DiscoveryS3002
Topics
Tuberculosis Research and EpidemiologyT10038Innovations in Medical EducationT10254Mathematical and Theoretical Epidemiology and Ecology ModelsT10482Bacterial Infections and VaccinesT10873Mycobacterium research and diagnosisT11316Health and Medical Research ImpactsT12168Zoonotic diseases and public healthT12492Infectious Encephalopathies and EncephalitisT13201
MeSH
DiseasesC
InfectionsC01
Analytical/Diagnostic/Therapeutic TechniquesE
DiagnosisE01TherapeuticsE02Investigative TechniquesE05
Phenomena & ProcessesG
Disciplines & OccupationsH
Health OccupationsH02
Health CareN
Health Care ServicesN02Health Care EconomicsN03Health Services AdministrationN04Health Care Quality & EvaluationN05Environment & Public HealthN06
ANZSRC FoR
Biological Sciences31
Microbiology3107
Biomedical & Clinical Sciences32
Clinical Sciences3202Immunology3204Medical Microbiology3207
Health Sciences42
Epidemiology4202Public Health4206
Mathematical Sciences49
Statistics4905

AI-generated content — verify with the issuing agency’s official FOA/NOFO. Not endorsed by HHS.

© 2026 Biostochastics, Seattle WA · Contact · Terms · About